Vinblastine and antihelmintic mebendazole potentiate temozolomide in resistant gliomas
Investigational New Drugs Sep 04, 2017
Kipper FC, et al. – Experts wish to find out if vinblastine (VBL) and antihelmintic mebendazole (MBZ) potentiate temozolomide (TMZ) in resistant gliomas. Study findings indicate that the triple combination of TMZ, VBL, and MBZ may be a considerable therapeutic alternative for the TMZ–tolerant gliomas that harbor low expression of FGFR3/AKT2.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
